Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (451-460 of 522) with videos related to

Pageof 53
Sort By:
The Journal of Urology|April 5, 2021
Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. LetterFranklin D Gaylis, Matthew R Cooperberg, Ronald C Chen, et al.
JAMA|March 22, 2017
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 YearsDaniel A Barocas, JoAnn Alvarez, Matthew J Resnick, et al.
European Urology|February 27, 2020
Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or ObservationAaron A Laviana, Zhiguo Zhao, Li-Ching Huang, et al.
European Urology Open Science|March 4, 2022
Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate CancerBenjamin H Press, Tashzna Jones, Olamide Olawoyin, et al.
European Urology Open Science|January 15, 2026
Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific OutcomesRyan M Putney, Purvish Trivedi, Shivanshu Awasthi, et al.
Prostate Cancer and Prostatic Diseases|August 12, 2024
Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort studySriram Deivasigamani, Eric S Adams, Shannon Stock, et al.
European Urology|June 2, 2018
The Diverse Genomic Landscape of Clinically Low-risk Prostate CancerMatthew R Cooperberg, Nicholas Erho, June M Chan, et al.
The Journal of Urology|June 23, 2020
Assessing the Quality of Surgical Care for Clinically Localized Prostate Cancer: Results from the CEASAR StudyPeter A Reisz, Aaron A Laviana, Zhiguo Zhao, et al.
Cancer|February 17, 2021
Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancerDario Pasalic, Daniel A Barocas, Li-Ching Huang, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2022
Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancerJacob E Tallman, Christopher J D Wallis, Zhiguo Zhao, et al.
Pageof 53

Showing results (451-460 of 522) with videos related to

Sort By:
Pageof 53
The Journal of Urology|April 5, 2021
Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. LetterFranklin D Gaylis, Matthew R Cooperberg, Ronald C Chen, et al.
JAMA|March 22, 2017
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 YearsDaniel A Barocas, JoAnn Alvarez, Matthew J Resnick, et al.
European Urology|February 27, 2020
Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or ObservationAaron A Laviana, Zhiguo Zhao, Li-Ching Huang, et al.
European Urology Open Science|March 4, 2022
Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate CancerBenjamin H Press, Tashzna Jones, Olamide Olawoyin, et al.
European Urology Open Science|January 15, 2026
Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific OutcomesRyan M Putney, Purvish Trivedi, Shivanshu Awasthi, et al.
Prostate Cancer and Prostatic Diseases|August 12, 2024
Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort studySriram Deivasigamani, Eric S Adams, Shannon Stock, et al.
European Urology|June 2, 2018
The Diverse Genomic Landscape of Clinically Low-risk Prostate CancerMatthew R Cooperberg, Nicholas Erho, June M Chan, et al.
The Journal of Urology|June 23, 2020
Assessing the Quality of Surgical Care for Clinically Localized Prostate Cancer: Results from the CEASAR StudyPeter A Reisz, Aaron A Laviana, Zhiguo Zhao, et al.
Cancer|February 17, 2021
Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancerDario Pasalic, Daniel A Barocas, Li-Ching Huang, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2022
Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancerJacob E Tallman, Christopher J D Wallis, Zhiguo Zhao, et al.
Pageof 53